4

Changes in Ownership

FATE THERAPEUTICS INC Filed 2023-04-17 Acc 0001104659-23-046353

Director sold 302,339 shares at $5.84 ($1,765,660)

Director bought 25,700 shares at $6.00 ($154,200)
Director disposed of 5,492,385 shares (other)
Director acquired 5,492,385 shares (other)
Director acquired 167,205 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Redmile Group, LLC Director	2023-04-13	Conversion	+167,205			13,135,758	I
Redmile Group, LLC Director	2023-04-14	Sale	−302,339	$5.84	$1,765,660	12,833,419	I
Redmile Group, LLC Director	2023-04-14	Other disposition	−5,492,385	$5.84	$32,075,528	12,833,419	I
Redmile Group, LLC Director	2023-04-14	Other acquisition	+5,492,385	$5.84	$32,075,528	12,833,419	I
Redmile Group, LLC Director	2023-04-14	Purchase	+25,700	$6.00	$154,200	12,859,119	I
Derivatives
Redmile Group, LLC Director	2023-04-13	Conversion · Class A Convertible Preferred Stock	−33,441			2,761,108	I
Redmile Group, LLC Director	2023-04-14	Other disposition · Class A Convertible Preferred Stock	−45,752	$29.20	$1,335,958	2,761,108	I
Redmile Group, LLC Director	2023-04-14	Other acquisition · Class A Convertible Preferred Stock	+45,752	$29.20	$1,335,958	2,761,108	I
Redmile Group, LLC Director	2023-04-14	Other disposition · Pre-Funded Warrants to Purchase Common Stock	−54,960	$5.84	$320,911	257,310	I
Redmile Group, LLC Director	2023-04-14	Other acquisition · Pre-Funded Warrants to Purchase Common Stock	+54,960	$5.84	$320,911	257,310	I
Redmile Group, LLC Director	2023-04-14	Other disposition · Cash-settled Swaps	−550,000	$5.84	$3,212,000	559,100	I
Redmile Group, LLC Director	2023-04-14	Other acquisition · Cash-settled Swaps	+550,000	$5.84	$3,212,000	559,100	I
Open-market purchases · 25,700 sh · avg $6.00 · $154,200
Open-market sales · 302,339 sh · avg $5.84 · $1,765,660